Color Access, Inc.

E-l Management Corporation

Premier Specialties Inc.

Jon Anderson

Thomas Mammone

Daniel H Maes

Lieve Declercq

Edward Pelle

Kenneth D Marenus

Christina G Fthenakis

Mary S Matsui

Donald F Collins

Warren Shapiro

Hugo A L Corstjens

Lieve Declerq

The invention relates to a method for improving skin lipid barrier function by applying to the skin a composition comprising effective amounts of a protease inhibitor and a cell differentiation enhancer. The composition is useful in promoting skin lipid barrier repair and maintaining the integrity of the lipid barrier. In this regard, the compositions can be used in the treatment and prevention of dry skin, and associated chrono/proto-aging conditions, in the treatment and prevention of irritation on the skin, in the treatment and prevention of UV-related damage to the skin, and in the enhancement of the retention of self-tanning.

Method and composition for improving skin barrier function

A new and improved cosmetic composition and method of using the same to prevent and treat chemically induced skin irritation and discoloration and protect from the adverse effects of tyrosinase containing a small but effective amount of ethyl p-methoxycinnamate derived from Kaempferia Galanga roots.

Compositions for prevention of chemically induced irritation and discolorations and methods of using same

The present invention relates to topical compositions useful in enhancing lipid synthesis in skin comprising an effective amount of cafestol or kahweol, or derivative thereof, in combination with a pharmaceutically or cosmetically acceptable carrier. Such compositions are useful in treatment or prevention of dry skin and conditions in which the skin's lipid barrier is defective or damaged.

Topical composition and method for enhancing lipid barrier synthesis

The invention relates to topical cosmetic and pharmaceutical composition for enhancing collagen levels in skin cells, the compositions comprising an effective amount of a biologically active phenolic compound-containing extract, or active fraction thereof, obtainable from

Compositions containing mimosa phenolic compounds

The present invention relates to a method of inhibiting angiogenesis in mammalian tissue which comprises supplying to the tissue a composition comprising an effective amount of epigallocatechin-gallate, epicatechin gallate or a combination thereof. The method is particularly useful in the treatment of angiogenesis-related skin conditions in which the catechin is applied topically, such as the treatment of various skin cancers, psoriasis, spider veins or undereye circles.

Method of treating topical angiogenesis-related disorders

Growing community of inventors

Galesburg, MI, United States of America

Jon Anderson